Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.798
Sell
RSI(14)
25.294
Sell
STOCH(KDJ)(9,3,3)
6.147
Oversold
ATR(14)
1.059
High Vlolatility
CCI(14)
-172.098
Sell
Williams %R
97.402
Oversold
TRIX(12,20)
-0.524
Sell
StochRSI(14)
0.000
Oversold
Omada Health Inc
OMDA11.650USD
-0.335-2.80%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
674.38MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Omada Health Inc
Currency: USD Updated: 2026-02-06Key Insights
Omada Health Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered undervalued, ranking 129 out of 482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 26.55.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Omada Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Omada Health Inc Highlights
StrengthsRisks
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 90.39% year-on-year.
Overvalued
The company’s latest PE is -15.38, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 488.16K shares of this stock.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
26.545
Target Price
+121.49%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of Omada Health Inc is 7.84, ranking 162 out of 482 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is high.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
4.08
Operational Efficiency
9.05
Growth Potential
8.72
Shareholder Returns
7.37
Omada Health Inc's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of Omada Health Inc is 7.35, ranking 260 out of 482 in the Software & IT Services industry. Its current P/E ratio is -15.38, which is 0.00% below the recent high of -15.38 and -64.03% above the recent low of -25.22.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 129/482
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Omada Health Inc is 7.64, ranking 239 out of 482 in the Software & IT Services industry. The average price target is 28.50, with a high of 33.00 and a low of 22.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
26.545
Target Price
+96.49%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
67
Total
7
Median
9
Average
Company name
Ratings
Analysts
Omada Health Inc
OMDA
11
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
28
HCA Healthcare Inc
HCA
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
23
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of Omada Health Inc is 6.39, ranking 363 out of 482 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 15.45 and the support level at 9.68, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
13.037
Sell
MA10
14.323
Sell
MA20
15.105
Sell
MA50
15.678
Sell
MA100
19.310
Sell
MA200
19.308
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-06Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Omada Health Inc is 4.61, ranking 250 out of 482 in the Software & IT Services industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
--
240-Day Volatility
--
Return
Best Daily Return
60 days
--
120 days
--
5 years
--
Worst Daily Return
60 days
--
120 days
--
5 years
--
Sharpe Ratio
60 days
--
120 days
--
5 years
--
Risk Assessment
Maximum Drawdown
240 days
--
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
--
3 years
--
5 years
--
Skewness
240 days
--
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
--
5 years
--
Standardised True Range
240 days
--
5 years
--
Downside Risk-Adjusted Return
120 days
--
240 days
--
Maximum Daily Upside Volatility
60 days
--
Maximum Daily Downside Volatility
60 days
--
Liquidity
Average Turnover Rate
60 days
--
120 days
--
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--
Peer Comparison
Software & IT Services
Omada Health Inc
OMDA
6.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
A10 Networks Inc
ATEN
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Visa Inc
V
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Progress Software Corp
PRGS
8.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Mastercard Inc
MA
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
DOX
8.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
